Fortrea, a provider of clinical development and patient access solutions to the life sciences industry, has selected Cognizant as strategic technology transformation provider.
Cognizant will revolutionize Fortrea’s global technology landscape as part of the four-year agreement. The project’s approach is anticipated to introduce the speed and flexibility necessary for deploying cutting-edge hybrid cloud systems and platforms, catering to a new era of digital innovation at Fortrea.
Fortrea recently completed its spin-off from its parent company in June 2023, aimed at enhancing agility and capitalizing on growth opportunities in clinical trials and patient access.
In 2024, Cognizant, one of the leading IT service providers, will play a crucial role in facilitating Fortrea’s transition from its agreements with its former parent company, ensuring a smooth shift and establishing a robust global infrastructure, application management, and end-user services for Fortrea.
The strategic services provided by Cognizant are anticipated to elevate Fortrea’s data and analytical capabilities, setting new standards in the Contract Research Organization (CRO) industry. Moreover, Fortrea expects to leverage Cognizant’s expertise in life sciences and healthcare technology to address the evolving needs of its customers, including leading enterprises in the industry.
“Today’s announcement reflects Fortrea’s renewed organizational agility following our spin-off. We are selectively investing in clinical applications and platforms that give us and our customers an advantage in the race to bring life-changing treatments to patients faster,” Alejandro Martinez Galindo, Chief Information Officer of Fortrea, said.
